Current Report Filing (8-k)
December 20 2017 - 4:27PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934
Commission File
Number:
333-202970
Sheng Ying Entertainment Corp.
|
(Exact name of Registrant as specified in its charter)
|
|
Nevada
|
|
30-0828224
|
(State of incorporation)
|
|
(IRS Employer ID Number)
|
|
|
|
5348 Vegas Drive, Las Vegas, NV 89108
|
Address of Principal Executive Office
|
|
Avenidida Doutor Mario Soares N. 320
Edificio Finance & IT Centre
5 Andar A
Macau
|
(Previous Address of principal executive offices)
|
|
(310) 982-1331
|
Registrant’s telephone number, including area code
|
Date of Report
(Date of earliest event reported):
December 19, 2017
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
At a Special Meeting of the Board of Directors of
Sheng Ying Entertainment Corp., a Nevada corporation, December 19, 2017, the Board adopted the following Resolutions:
|
1)
|
authorizing the Company seek, through a private placement memorandum, to raise up to a maximum of US$2,000,000.00 through the
sale of a maximum of 2,000,000 shares of the Company’s restricted Common Stock, at a sale price of US$1.00 per share. The
Directors shall have total discretion to sell less than the 2,000,000 shares;
|
|
2)
|
authorizing the Company to present to shareholders for approval an amendment to the Company’s
Articles of Incorporation to effect the change of the Company’s name to “
VITALIBIS, INC
., all pursuant to applicable
Nevada state laws, rules and regulations, as well as the Company’s Bylaws;
|
|
3)
|
authorizing the total issued and outstanding shares of Common Stock of the
Company to be forward split on the basis of 2.5 for 1, as of December 31, 2017, or upon approval of the split and name change by
FINRA, which ever first occurs. The effect of the split would result in each one (1) share of the Common Stock issued and outstanding
to become two and one-half (2½) shares. The total authorized shares would remain at 50,000,000 (45,000,000 shares of Common
Stock and 5,000,000 shares of Preferred Stock), par value remaining at $.001 per share. Any fractional shares resulting from the
split shall be rounded up to the next whole number;
|
|
4)
|
directing the officers and the Company’s corporate and securities counsel
work together and take any and all actions, and execute any and all documents deemed necessary and appropriate, to effect the Resolutions
adopted herein, including coordinating the protocols for approval of the name change by shareholders, consistent with Nevada corporate
law (NRS Ch. 78), together with actions to file and notify regulatory authorities of this action, as well as the forward split
and otherwise comply with all applicable laws, rules and regulations, including coordinating with FINRA on the change of the Company’s
name, forward split and change of symbol and CUSIP number; and
|
|
5)
|
directing the officers and the Company’s corporate and securities counsel
to work together on the private placement, and take any and all actions to insure the Company’s compliance with the Securities
Act of 1933, as amended (the “Act”), and Regulation D promulgated thereunder, to insure that the proposed offering
will be exempt from registration under state and federal securities laws, rules and regulations applicable to publicly trading
companies offering securities and raising capital without a filing a registration statement for same, together with actions to
file and notify regulatory authorities of this action, and otherwise comply with all applicable state and federal laws, rules and
regulations. It is specifically stipulated that the proposed offering shall be made to a limited number (no more than 10) “accredited
investors”, as that term is defined in Regulation D promulgated under the Act.
|
(d) Exhibits
.
The exhibits listed
in the following Exhibit Index are filed as part of this Current Report on Form 8-K:
________________
Signatures
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 20, 2017
SHENG YING ENTERTAINMENT CORP.
By:
/s/ Steve Raack
Steve Raack
President and Chief Executive Officer
Vitalibis (CE) (USOTC:VCBD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vitalibis (CE) (USOTC:VCBD)
Historical Stock Chart
From Apr 2023 to Apr 2024